Purchases and Sales Made in Q1 2022 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q1 2022. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-259K- 36.0% |
$1.55M - $2.21M
|
460K
$0
|
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-329K- 45.6% |
$1.97M - $2.81M
|
392K
$0
|
|
|
May 13, 2022
Q1 2022
|
Candriam S.C.A.
|
SELL
|
- |
-337KClosed |
$2.03M - $2.88M
|
0
$0
|
|
|
May 10, 2022
Q1 2022
|
Trv Gp Ii, LLC
Boston, MA |
SELL
|
- |
-1.35M- 50.04% |
$8.11M - $11.5M
|
1.35M
$0
|
|
|
May 16, 2022
Q1 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-1.36MClosed |
$8.17M - $11.6M
|
0
$0
|